BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35385881)

  • 1. Administration of Orexin-A into the Rat Thalamic Paraventricular Nucleus Enhances the Naloxone Induced Morphine Withdrawal.
    Babaie F; Kourosh-Arami M; Farhadi M
    Drug Res (Stuttg); 2022 Apr; 72(4):209-214. PubMed ID: 35385881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA Receptors in the Rat Paraventricular Thalamic Nucleus Reduce the Naloxone-induced Morphine Withdrawal.
    Babaei F; Kourosh-Arami M; Farhadi M
    Cent Nerv Syst Agents Med Chem; 2023; 23(2):119-125. PubMed ID: 37587828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
    Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal.
    Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    J Physiol Sci; 2019 Mar; 69(2):281-293. PubMed ID: 30406600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats.
    Ahmadi-Soleimani SM; Ghaemi-Jandabi M; Azizi H; Semnanian S
    Neurosci Lett; 2014 Jan; 558():62-6. PubMed ID: 24211689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
    Li Y; Wang H; Qi K; Chen X; Li S; Sui N; Kirouac GJ
    Physiol Behav; 2011 Jan; 102(1):42-50. PubMed ID: 20951152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of orexin type-1 receptors (OX1Rs) attenuates naloxone-precipitated morphine withdrawal syndrome in rat dorsal hippocampus.
    Hooshmandi M; Hosseinmardi N; Janahmadi M; Khakpai F; Rohampour K; Doostmohammadi J
    Pharmacol Biochem Behav; 2017 Jul; 158():39-48. PubMed ID: 28583577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated Administration of Orexin into the Thalamic Paraventricular Nucleus Inhibits the Development of Morphine-Induced Analgesia.
    Samani F; Arami MK
    Protein Pept Lett; 2022; 29(1):57-63. PubMed ID: 34906051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent effects of the orexin-1 receptor antagonist SB-334867 on naloxone precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine dependent rats.
    Kourosh-Arami M; Joghataei MT; Komaki A; Gholami M; Najafi Z; Lavaie M
    Int J Neurosci; 2022 Jan; 132(1):67-76. PubMed ID: 32746675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal.
    Laorden ML; Ferenczi S; Pintér-Kübler B; González-Martín LL; Lasheras MC; Kovács KJ; Milanés MV; Núñez C
    PLoS One; 2012; 7(5):e36871. PubMed ID: 22590628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons.
    Fakhari M; Azizi H; Semnanian S
    Neuroscience; 2017 Nov; 363():1-10. PubMed ID: 28888954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin type-1 receptor inhibition in the rat lateral paragigantocellularis nucleus attenuates development of morphine dependence.
    Rezaei Z; Kourosh-Arami M; Azizi H; Semnanian S
    Neurosci Lett; 2020 Apr; 724():134875. PubMed ID: 32114118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central blockade of orexin type 1 receptors reduces naloxone induced activation of locus coeruleus neurons in morphine dependent rats.
    Aghajani N; Pourhamzeh M; Azizi H; Semnanian S
    Neurosci Lett; 2021 Jun; 755():135909. PubMed ID: 33892002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats.
    Mousavi Y; Azizi H; Mirnajafi-Zadeh J; Javan M; Semnanian S
    Neurosci Lett; 2014 Aug; 578():90-4. PubMed ID: 24970749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
    Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
    Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal.
    Davoudi M; Vijeepallam K; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    J Neural Transm (Vienna); 2019 Nov; 126(11):1425-1435. PubMed ID: 31493096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones.
    Laorden ML; Núñez C; Almela P; Milanés MV
    J Neurochem; 2002 Oct; 83(1):132-40. PubMed ID: 12358736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.
    Sharf R; Sarhan M; Dileone RJ
    Biol Psychiatry; 2008 Aug; 64(3):175-83. PubMed ID: 18423425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of orexin-1 and -2 receptors within the nucleus accumbens in the acquisition of sensitization to morphine in rats.
    Assar N; Mahmoudi D; Mousavi Z; Zarrabian S; Haghparast A
    Behav Brain Res; 2019 Nov; 373():112090. PubMed ID: 31325517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
    Fuertes G; Laorden ML; Milanés MV
    Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.